eye treatment biosimilar

Debt financing Korea Securities Finance eyes its 1st foreign bond sale in 2026

Korea Securities Finance Corp. (KSF) is preparing to issue its first foreign currency-denominated bonds in 2026 to provide low-cost funding to domes...

Earnings KakaoBank posts record Q1 profit, eyes Thai expansion after Indonesia

KakaoBank Corp., a leading South Korean internet-only bank, posted its highest quarterly profit in the first quarter, defying a drop in interest inc...

Bio & Pharma Korea’s pharmaceutical exports set to top $10 bn, led by ‘K-M7’ champions

South Korea’s pharmaceutical exports are on course to surpass $10 billion this year, underscoring the country’s growing clout in the glo...

Corporate strategy KT&G eyes overseas M&A after rejecting activist fund's offer

KT&G Corp., South Korea’s dominant tobacco and ginseng producer, is seeking to acquire a Japanese ginseng company after dismissing a 1.9-t...

IPOs LG Electronics eyes India IPO delay, says plan in flux

LG Electronics Inc. is mulling putting off an initial public offering of its wholly owned subsidiary in India amid growing volatility in the global ...

Electronics LG Display eyes turnaround on China's shift to OLED

LG Display Co., the world’s top large-sized organic light-emitting diode (OLED) panel maker, will likely swing to profit this year for the fir...

Real estate S.Korean gaming giant Netmarble eyes headquarters building sale

Netmarble Corp., a leading South Korean gaming company, is seeking to sell its headquarters building in Seoul, which could fetch up to 800 billion w...

Bio & Pharma Celltrion expands footprint in Latin America with flagship oncology drugs

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

Automobiles Kumho Tire eyes Poland, Serbia, Portugal for 1st European plant

Kumho Tire Co., South Korea’s No. 2 tire maker, is evaluating Poland, Serbia and Portugal as a potential site for its first plant in Europe as...

Private equity EQT set to invest in KKR-backed fashion unicorn Musinsa

EQT, Europe's largest private equity firm, is set to invest 20 billion to 30 billion won ($14 million-$21 million) in Musinsa, South Korea’s f...

Steel POSCO eyes investment in Hyundai Steel’s US plant

POSCO, the world’s seventh-largest steelmaker, is seeking to invest in smaller rival Hyundai Steel Co.'s first overseas plant in the US, in ex...

Bio & Pharma Celltrion wins Australian approval for eye, bone disease biosimilars

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

Steel POSCO eyes deeper steel, energy ties with global peers

POSCO Group, South Korea’s steelmaking giant, will further bolster its competitiveness in the global steel market and energy value chains thro...

Mergers & Acquisitions IMM consortium owns 100% of Hyundai LNG Shipping; Stake sale eyed

A consortium of IMM Private Equity Inc. and IMM Investment Corp. has secured full ownership of Hyundai LNG Shipping, South Korea’s top liquefi...

Bio & Pharma Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

Business & Politics Korea eyes laws akin to US AMPC to offer subsidies for its battery makers

South Korea, home to global top battery makers such as LG Energy Solution Ltd., SK On Co. and Samsung SDI Co., is seeking to enact laws that would l...

Electronics LG Electronics restarts home appliance plant in Russia

LG Electronics Inc. has resumed operations at its home appliance plant in Russia amid prospects of a ceasefire between Russia and Ukraine, signaling...

Korean chipmakers Samsung to expand in robotics, medtech; eyes sizeable M&As

Samsung Electronics Co. will accelerate its push into robotics, medical technology and next-generation semiconductor markets to secure new growth dr...

Shipping & Shipbuilding Samsung Heavy eyes $5.5 bn FLNG ship deals as Trump sanctions China

GEOJE, South Gyeongsang – At a huge shipyard operated by Samsung Heavy Industries Co. on Geoje, an island in South Gyeongsang province some 39...

Bio & Pharma Samsung, Celltrion lead biosimilar market in Europe, US

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...

Real estate European student housing is top of the class: Savills IM

The appeal of European purpose-built student accommodation (PBSA) to real estate investors is growing rapidly. In the recent 2025 INREV Investor Int...

Energy Hyosung to double transformer output to conquer US market

MEMPHIS, Tenn. -- South Korea’s major power system and machinery conglomerate Hyosung Heavy Industries Corp. plans to nearly double its annual...

Shipping & Shipbuilding US Defense Secretary Pete Hegseth eyes March visit to Seoul

US Defense Secretary Pete Hegseth is arranging a visit to South Korea next month to inspect shipyards and discuss cooperation on naval vessel constr...

Bio & Pharma Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Bio & Pharma Korean court rules in favor of Samsung Bioepis over Regeneron’s Eylea

A South Korean court on Friday ruled in favor of Samsung Bioepis Co. in a patent dispute against Regeneron Pharmaceuticals Inc., a US pharmaceutical...

Aerospace & Defense S.Korea’s Hanwha eyes L-SAM exports with UAE’s EDGE  

Hanwha Group’s Vice Chairman and heir apparent Kim Dong-kwan is on the front line to export South Korea's latest homegrown air defense system ...

Corporate restructuring SK Ecoplant seeks to sell waste treatment business for $1.4 billion

SK Ecoplant Co., a South Korean construction engineering and waste management company under SK Group, is seeking to dispose of its waste treatment b...

Mergers & Acquisitions LG Chem embarks on sale of dermal filler business worth $343 million

LG Chem Ltd., the world’s fourth-largest chemicals producer that is fostering vaccine and new drug development as new growth drivers, has kick...

Real estate NPS closes $1.6 bn Korean office deal; scientists pension eyes NCSOFT building

The National Pension Service (NPS) has completed the purchase of One Grove for 2.3 trillion won ($1.6 billion), its largest single real estate inves...

Bio & Pharma Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...